SenzaGen AB (SZGEF) Analyst/Investor Day Transcript

Rodney Alfvén

Good day, and welcome to this Capital Markets Day for SenzaGen, both for those of you who are online and those of you who are audience in the room. My name is Rodney Alfvén, and I will be the moderator for today. This event will provide an in-depth overview of the strategic priorities of SenzaGen as well as the value-creating initiatives that will drive the company towards a profitable growth.

So the agenda for today is there will be an introductory remark from the Chairman of SenzaGen, Carl Borrebaeck. He is also a professor at the University of Lund in Immunology as well as a founder of the company and a significant shareholder. That will then be followed by a presentation of the CEO and President, Mr. Peter Nahlstedt, who will guide you through the strategic initiatives and also talk about the financials and the financial outlook. Then there will be Ian Kimber, Professor in Toxicology at the University of Manchester. He is also a member of the Board and a key opinion leader, who will talk to you about the allergy. That will then be followed for a break. And then after the break, there will be a presentation from Henrik Johansson, the Chief Scientist; and Andy Forreryd, the Vice President in Sales.

There will also be a testimony of an honorable customer via a video. That will then be followed by a Q&A session, where both of you online will have the opportunity to ask questions, and you can actually start already now in the designated field that